Having trouble accessing articles? Reset your cache.

June 24 P&P Quick Takes: Priority generics in China; plus CMS price transparency and more

China publishes list of generic drugs for priority approval
To encourage development of generic drugs, China’s National Health Commission (NHC) announced the country's first annual list of 34 off-patent and soon to be off-patent drugs,

Read the full 347 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers